Roger leads analytical development at Kincell Bio, where he builds phase-appropriate, scalable assay strategies for cell therapy programs and is known for transforming complex biology into reliable data. Before joining Kincell, Roger held analytical leadership positions at influential organizations in the biologics space, including Inceptor Bio and Arranta Bio (now Recipharm Advanced Bio). Roger earned his Ph.D. in Molecular Basis of Disease from the Medical University of Ohio at Toledo and a M.S. in Clinical Laboratory Sciences from Michigan State University.